Cytarabine

Cytarabine (ara-C) is a deoxycytidine nucleoside analogue that inhibits DNA polymerase after intracellular phosphorylation, used as a cornerstone agent in acute myeloid leukaemia and other haematological malignancies. Simson Pharma's Cytarabine reference standard and impurities support stability-indicating method development for this critical oncology drug.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cytarabine Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Cytarabine
Cytarabine EP Impurity F
Cytarabine Impurity G
Cytarabine Impurity EP H
Cytarabine EP Impurity I
Cytidine Impurity 1
2,3-O-Sulphinyl Cytidine
Cytarabine Impurity 33

Isotope Labelled Compounds

Cytarabine-13C3
Cytarabine-13C-15N2